© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
April 18, 2012
Letter from the Publisher
News & Trends
What Your Patients Are Reading
Marc Rothenberg, MD, PhD: EoE Receives First FDA Approval with Dupilumab
Systematic Review Suggests Oral JAK Inhibitors Effective in AD
Study Identifies 24 Adverse Events Associated with Secukinumab Treatment